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KEY TO MASTER CHART 
Age  
17-20 years - 1 
21-25 years - 2 
26-30 years - 3 
31-35 years - 4 
36 - 40 years - 5 
 
Socio Economic Status  
Class I - A 
Class II - B 
Class III - C 
Class IV - D 
Class V - E 
 
BMI 
<  20 - A 
21– 24 - B 
25 - 29 - C 
> 30 - D 
 
FAMILY HISTORY 
Positive - + 
Negative - - 
 
GESTATIONAL AGE AT TESTING 
16-20 weeks - 1 
21-24 weeks - 2 
25-28 weeks - 3 
29-32 weeks - 4 
 
OBSTETRICS CODE 
G1(Gravida  1)  - I 
G2 (Gravida 2) - II 
G3(Gravida  3) - III 
G4 (Gravida 4) - IV 
G5 (Gravida 5) - V 
G6 (Gravida 6) - VI 
 
RISK FACTORS IN PREVIOUS PREGNANCY 
Spontaneous Abortion  - SA 
Macrosomia     - M 
Sudden Intrauterine Death  - SID 
Unexplained Still Birth  - USB 
Unexplained Neonatal Death  - UND 
History of GDM    - HG 
History of PIH    - HP 
Congenital Anomaly   - CA 
 
RISK FACTORS IN PRESENT PREGNANCY -  
Obesity     - OB 
Pregnancy Induced Hypertension - PIH 
Hydramnios      - H 
Glucosuria     - G 
Congenital Anomaly   -  CA 
Macrosomia     - M 
Recurrent UTI     - RU 
Moniliasis     - MON 
GESTATIONAL AGE AT DELIVERY 
Term             - T 
 Preterm      - PT 
BIRTH WEIGHT (Kg) 
2 – 2.4     - A 
2.5 – 2.9     - B 
3 – 3.4     - C 
3.5 – 3.9     - D 
> 4     - E 
 
APGAR SCORE 
8 and above      - A 
5 – 7      - B 
1 – 4     - C 
 
NEONATAL COMPLICATIONS 
Hypoglycemia     - HG 
Hypocalcemia     - HC 
Hyperbilirubinemia   - HB 
Respiratory Distress Sydrome - RDS 
CA     - Congenital Anomaly 
  
    
INTRODUCTION 
Diabetes Mellitus is a clinical syndrome characterized by hyperglycemia 
due to absolute or relative deficiency of insulin. Lack of insulin whether absolute 
or relative affects the metabolism of carbohydrate, protein, fat(1). 
Pregnancy is characterised by mild fasting hypoglycemia, post prandial 
hyperglycemia, hyper insulinism and insulin resistance- a diabetogenic stress. 
Normally pregnant woman elaborates an increased insulin production by 30% 
above her non pregnant state. A woman who is unable to achieve adequate 
insulinogenic compensation develops Gestational Diabetes. Pregnancy unmasks 
the minor intolerance of carbohydrate metabolism in subjects with reduced 
pancreatic islet cell reserve.(2) 
Gestational Diabetes was defined as carbohydrate intolerance of variable 
severity with its onset or first recognition during pregnancy. Use of this term was 
encouraged in order to communicate the need for increased surveillance and to 
convince the woman of  the need for further testing postpartum.(3) 
Gestational Diabetes is often asymptomatic and associated with increased 
fetal and neonatal morbidity and mortality.Good glycemic control reduces the risk 
of complication(4). 
CARBOHYDRATE METABOLISM IN NON DIABETIC PREGNANCY(5) 
Factors contributing to insulin resistance  
Production of placental somatomammotrophin, increased production of 
estrogen, progesterone, increased insulin destruction by placental enzyme like 
insulinase. 
Changes in Gluconeogenesis 
Fetus continuously uses fuels from the mother.It uses alanine and other 
amino acids and depletes the mother of a major gluconeogenic source. 
Increased Lipolysis 
The mother uses fat for caloric needs and saves glucose for the fetus. 
METABOLIC CHANGES DURING FASTING 
During fasting there is decrease in plasma glucose and amino acids. There 
is higher plasma concentration of free fatty acids, triglycerides. During fasting for 
a longer period there is switch in metabolism from glucose to lipid which is 
termed “accelerated starvation” by Freinkel (8) 
METABOLIC CHANGES DURING FED STATE(5) 
During the first few hours, glucose absorbed from the gastro intestinal 
tract provides for the metabolic needs of brain and other organs. The absorbed 
glucose in excess of these needs is used to rebuild fuels in liver, muscle , fat and 
to provide supply of glucose for the fetus. This is facilitated anabolism. 
 
REVIEW OF LITERATURE 
HISTORY 
Diabetes was described more than 2000 years ago. An ancient 
documentation by Susruta in India at about 400 B.C. has described the diabetic 
syndrome as characterized by a “honeyed urine”. The word Diabetes (to flow 
through) was coined by Greek physician Aretaus of Cappadocia in first century 
(150 A.D) from the word siphon (sweet taste). The word mellitus (honeyed) was 
added by John Rollo in 18th century. In 1674, Thomas Willis, a Physician, 
Anatomist and a professor of Natural philosophy at Oxford discovered by tasting 
that the urine of diabetic persons was “wonderfully sweet as if imbued with honey 
or sugar”. Willis could not explain the chemical nature of the sweet substance. It 
was Mathew Dobson of Manchester, England who in 1776 demonstrated that 
diabetics actually excrete sugar in urine. It was John Rollo, surgeon general of 
Royal artillery who first applied the discovery of glycosuria by Dobson to the 
quantitative metabolic study of diabetes. 
It was Claude Bernard who studied the association between pancreas and 
Diabetes. The name Insulin was coined by De Mayer (1909). In 1921 Fredrick 
Banting and Charles Best with the help of Chemist J.B.Collip succeeded in 
fulfilling all of the criteria for therapeutic active Insulin. 
 Glucose homeostasis reflects a precise balance between hepatic glucose 
production and peripheral glucose uptake and utilisation. Insulin is the most 
important regulator of this metabolic equilibrium,but neural input,metabolic 
signals and hormones result in integrated control of glucose supply and 
utilization. In the fasting state low insulin levels increase glucose production by 
promoting hepatic gluconeogenesis and glycogenolysis and reduce glucose uptake 
in insulin sensitive tissue. Glucagon also stimulates glycogenolysis and 
gluconeogenesis by the liver and renal medulla. Post prandially the glucose load 
elicits a rise in insulin and fall in glucagon. The major portion of post prandial 
glucose is utilized by skeletal muscles, an effect of insulin stimulated glucose 
uptake(6). 
PATHOPHYSIOLOGY OF PERINATAL MORBIDITY 
The  Pedersen  hypothesis suggested that in diabetic pregnancy maternal 
hyperglycaemia is rapidly translated into foetal hyperglycaemia. The foetal 
pancreas responds to this glycaemic stimulus with islet cell hypertrophy and 
hyperplasia and foetal hyperinsulinism results. It is the foetal hyperinsulinemia 
that results in diabetic fetopathy or perinatal morbidity seen in such pregnancies. 
According to modified Pedersen hypothesis the non glucose secretagogues for 
foetal pancreatic insulin also play a role in perinatal morbidity(59).  
PATHOGENESIS OF PERINATAL MORTALITY AND MORBIDITY 
 
MODIFIED PEDERSEN / FRIENKEL’S  HYPOTHESIS 
The transport of maternal fuel to the foetus requires normal placental 
intermediary metabolism and normal supply of substrates. Because diabetes 
may result in markedly abnormal concentrations of maternal glucose, fatty 
acids, triglycerides and amino acids these may get transported to the foetus.  
Unlike the foetus of early gestation, the foetus of the late gestation is well 
equipped to synthesise and replace insulin from its pancreas and protect 
itself against brunt of abnormal fuel mixture, thereby normalizing blood 
sugar in circulation but in the process resulting in hyperinsulinemia of the 
foetus and due to its anabolic action causes macrosomia and associated 
complications.  
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Gestational carbohydrate intolerance is asymptomatic. The subjects 
destined to develop gestational diabetes mellitus have limited pancreatic 
insulin reserve and reduced insulin sensitivity. The stress of pregnancy due 
to counter insulin hormones overwhelms the insulin reserves. Hence in the 
plasma, levels of all classes of fuels – aminoacids, fatty acids and glucose 
are elevated which are delivered to the foetus. This change is seen more 
during the latter half of pregnancy when counter insulin factors and insulin 
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resistance is experienced.  The foetal transportation of abnormal fuels result 
in hyperinsulinemia and the resultant macrosomia. Thus macroscomia and 
associated  risk factors like traumatic delivery, RDS, neonatal 
hypoglycemia, hypocalcaemia, hyperbilirubinemia become the major 
concern for the subjects with gestational diabetes. 
 
FRIENKEL’S FUEL MEDIATED TERATOGENESIS 
 
 
 
 
 
 
Effects of abnormal glucose tolerance on the mother and the foetus: 
On the mother:  
¾ Pre-eclampsia and pregnancy induced hypertension(40)  is seen in 13.7% in 
Gestational Diabetes Mellitus, and 14.1% to 27% in established diabetes 
mellitus. Pre - eclampsia and pregnancy induced hypertension are more 
common in patients with Gestational Diabetes than in controls(41). Combs et 
al and Rosenn et al(42)  reported a significant association between poor 
glycaemic control and pre -eclampsia or pregnancy induced hypertension. 
¾ The incidence of chronic hypertension(43)  is 2.5% among Gestational 
Diabetes, against 0.3% in the non diabetic control group. 
¾ Overall incidence of ketoacidosis is 0.7% especially following beta agonist 
therapy. Kilvert et. al., reported one case of diabetic ketoacidosis in 150cases 
of Gestational Diabetes Mellitus.(44). Diabetic ketoacidosis is preventable 
and the prevention can be accomplished with optimal glycemic control. 
¾ The incidence of Hydramnios ranges from 2.0 to 2.1%(45)  in gestational 
diabetes mellitus and it is about 20% to 30% in overt diabetics. Most infants 
of hydramniotic diabetic pregnancy are structurally normal, associated with 
increased incidence of preterm labour and premature rupture of membrane. 
¾ Pyelonephritis was reported in 1.2% of gestational diabetes mellitus and 
3.6% of overt diabetes(43). There is no difference in the incidence of 
pyelonephritis in gestational diabetes mellitus and control groups. 
¾ Preterm labour complicated 8.1% of gestational diabetes mellitus and there is 
no significant difference in the preterm labour rate between gestational 
diabetes mellitus and control groups. There is significant correlation between 
preterm labour and uro-genital infection. (Candida and Trichomoniasis). 
Molsted and Pedersen(46) speculated that, hormonal differences increased the 
frequency of preterm labour in a diabetic than in non-diabetic women. 
¾ Spontaneous pre-term delivery is one of the important contributors to 
perinatal mortality in diabetic pregnancies.(46). In a Scandinavian report by 
Molsted and Pedersen, the incidence of preterm labour with delivery was 
14.6% in gestational diabetes mellitus versus 18 to 24% in established 
diabetes mellitus, and in the control group it was 12%. 
¾ The incidence of primary caesarean section among gestational diabetes 
mellitus women ranged from 13.4% to l8.4%(47)  and in controls 12.9% but 
repeat section in gestational diabetes mellitus was 16.5% and 6% among the 
control groups. There is a higher total caesarean section rate in gestational 
diabetes mellitus than controls(55). 
 
Foetal Problems associated with maternal hyperglycemia 
 
First Trimester Second trimester Third Trimester 
Malformations Hypertrophic 
Cardiomyopathy 
Hypoglycemia 
Growth retardation 
Foetal wastage 
Polyhydramnios 
Placental insufficiency 
Hypocalcemia 
Hyperbilirubinemia 
 Pre-eclampsia 
Foetal loss 
Low IQ 
Respiratory – 
Distress Syndrome 
Macrosomia 
Hypomagnesemia 
Intrauterine death 
 
¾ Hypoglycemia is one of the common causes for perinatal morbidity. It is 
defined as blood sugar level less than 40mg% in any infant regardless of 
gestational age. About 50% of the hypoglycemic babies may remain 
asymptomatic. The factor mainly protective against foetal hypoglycemia is the 
optimal control of maternal hyperglycemia especially during the third 
trimester and during labor. It has been shown that a mean maternal plasma 
glucose >105 mg/dl during the last four hours of labour in a diabetic mother 
leads to a higher incidence of neonatal hypoglycemia. 
¾ About 25% of the infant of diabetic mothers may present with serum calcium 
of <7 mg/dl and this may remain mostly asymptomatic and is usually 
detectable during the 2nd and 3rd day of birth. Hypomagnesemia may coexist 
and may require correction. 
¾ Respiratory distress syndrome (RDS) occurs in about 5% of the infant of 
diabetic mothers and it is seen equally in gestational diabetes mellitus. Again 
a strict glycaemic control reduces the incidence of RDS. 
¾ Polycythemia is relatively common in infant of diabetic mother. The 
hyperviscosity due to Polycythemia may induce congestive heart failure and 
vascular thrombosis accounting for the increased risk of renal vein thrombosis 
in these infants. 
¾ Hyperbilirubinemia, the common abnormality is due to increased bilirubin 
production and decreased life span of the RBCs with glycosylated cell 
membranes. Hepatic conjugation of bilirubin may be impaired due to an 
immature liver. 
 
Gestational Diabetes Mellitus is mostly the forerunner of Type-2 
Diabetes Mellitus(9). Like type-2 Diabetes mellitus ,obesity and advanced 
maternal age increase the risk of gestational diabetes mellitus(10,11). 
PREVALENCE 
Ethnically Indian women are more prone to develop glucose intolerance 
during pregnancy and have eleven fold increased risk compared to white 
caucasian necessitating universal screening during pregnancy(7). 
Prevalence of Gestational Diabetes is 2% to 5% of all pregnancies in  the 
UnitedStates(12). Marked variation has been reported in the prevalence of 
gestational diabetes world wide.  The frequency of gestational diabetes mellitus  
ranged widely from 0.15% to as high as 50% in pima Indians in the USA.(13). 
Ethnic and Racial differences in prevalence 
Hispanic, Native American, Asian, African American are racial / ethnic 
groups with an increased risk of developing diabetes.  Asian races are pointed out 
as one of the groups with highest prevalence of diabetes (14). Like racial and ethnic 
groups, positive family history of diabetes, older mothers, heavier women are the 
other risk factors. Woman of  oriental, first generation Hispanics from Indian 
subcontinent and middle east are at an increased risk for Gestational Diabetes (15).  
According to Beischer et al 1991, the prevalence of GDM in Indian subcontinent 
is 15%. 
Screening for GDM is important as detection and treatment of GDM is 
helpful in reducing maternal and perinatal mortality and morbidity. 
Following are the risk factors for screening of GDM. 
a) Age  > 25 years 
b) Diabetes Mellitus in first degree relatives. 
c) Multiparity 
d) Previous GDM 
e) Past history of large for dates baby 
f) Past history of still birth 
g) Repeated pregnancy loss 
h) Previous congenital malformations 
i) Past history of difficult labor 
j) Recurrent vaginal moniliasis 
k) Recurrent UTI 
l) Maternal obesity 
m) Hydramnios 
n) Pregnancy induced hypertension 
o) Glucosuria 
p) Previous history of unexplained  neonatal death 
SCREENING TEST : 
Various Screening Tests for GDM are  
1) Urine glucose (Glucosuria) 
2) Spot Test(7) 
3) Fasting Plasma Glucose 
4) Random Plasma Glucose 
5) O.Sullivan’s Oral Glucose Challenge Test 
6) WHO OGCT 
7) Glycosylated Hemoglobin (HbA1c) 
8) Fructosamine 
1) URINE GLUCOSE (GLUCOSURIA) 
Glucosuria occurs in pregnancy due to the fact that there is increased 
glomerular filtration rate, intermittent tubular defect in glucose absorption  and 
reduced renal threshold(7).  In a study  by Sutherland  et al it was found that 11% 
of obstetric population had glucosuria at sometime but fewer than 1% with 
glucosuria had abnormal GTT. Detection of  glucose in the urine is the simplest 
screening procedure. Unfortunately glucosuria is less specific as a screening 
test(16 ). 
2) SPOT TEST(7) 
Seshiah et al in 1984, used spot glucose test to detect glucose intolerance 
during pregnancy as an alternative simple screening procedure.  971 pregnant 
women at various stages of gestation at Institute of Obstetrics and Gynecology, 
Chennai were screened with spot test. Venous blood was obtained at the time of 
consultation after ascertaining the time at which the subject last had anything to 
eat.  Interval between the time of last meal and time of collection of blood sample 
was corrected to the nearest 30 minutes.  Interval of over 3 hours was interpreted 
as fasting sample .Whole blood glucose was estimated by O-Toludine method. 
The +2 SD figure of the spot test blood glucose is 85mg% fasting and 105mg% 
non fasting. The approximate plasma glucose values will be around 90mg% and 
120mg% respectively.  In a pregnant women the fasting and the non fasting 
glucose value never exceed the above figures. This test has value of sensitivity 
and specificity comparable to O-Sullivan’s screening test. 
3) FASTING PLASMA GLUCOSE 
Sacks et al (17) and Daniele et al (18)  observed that fasting plasma glucose 
is an easier screening procedure and suggested a cut off value of 95mg% for 
GDM. However such level  is insufficient as the sole marker of GDM since most 
cases have  FPG values below the putative threshold(19). Very few women are 
diagnosed with GDM on the basis of elevated fasting plasma glucose.  Nowadays 
fasting plasma glucose is not considered as a screening test. 
4) RANDOM PLASMA GLUCOSE 
Random blood glucose is a simple way to screen for abnormal glucose 
tolerance.  A positive cut off was taken as 115mg%, if women were tested less 
than 2 hrs after a meal and 105mg% if more than 2 hr after a meal.  It was 40%  
sensitive and 90% specific(16).  According to Stangenberg et al the threshold 
value for Random blood glucose was 116mg%.  With this cutoff, only 11.6% 
showed abnormal value. Random plasma glucose is useful for a noncompliant 
patient or  in circumstances in which glucose challenge drinks are not available. 
5) O.SULLIVAN’S ORAL GLUCOSE CHALLENGE TEST.  
It is otherwise known as universal screening test of O Sullivan. This 
consists of giving a 50gm glucose irrespective of the patients feeding state and 
time of day and estimating plasma glucose after  1 hour and taking cut off of > 
140mg/100ml for performing the diagnostic 100gm 3 hour oral glucose tolerance 
test.  It was found that when the cut off of 140mg/dl  was used it would identify 
80% of women with Gestational Diabetes. Using a value of 130mg/dl or more 
increases the yield to more than 90%(7).  This procedure involves the patient 
waiting for 1 hour following glucose ingestion  and positive screening test to have 
a second glucose load for diagnosis and it is costly. 
6) WHO OGCT 
Like WHO OGTT WHO suggested an oral glucose challenge test with 
same glucose load (75g) and estimation of glycemia after 2 hr for screening. 
WHO detected an intermediate state between diabetes mellitus and normal 
glucose tolerance, the reduced glucose tolerance.  Normal plasma glucose by this 
oral glucose challenge test is < 140mg% in  2 hours after 75g glucose load33.  The 
cut off for diabetes mellitus is  > 200mg% and that of impaired glucose tolerance 
is between 140-200. The impaired glucose tolerance is GDM by WHO.  
Study conducted at Agakhan University in Karachi, Pakistan, 1992 
showed that with the threshold of 140mg  %, 8.6% of screened population had 
abnormal glucose values(33). 
7 ) GLYCATED BLOOD PROTEINS  
a) Glycosylated Hemoglobin (HbA1c) 
Glycated hemoglobin is the linkage between glucose and hemoglobin.  
Glycosylated Hb is a measure of the control of glycemia over the previous 2 to 3 
months. It may be useful only in the retrospective documentation of GDM. 
In pregnant women with GDM,  there is fasting hypoglycemia, increased 
erythropoeisis, less glycated Hb and fluctuations in  blood glucose level due to 
rapid change in hormonal milieu.  So HbA1c is not much effective.In normal 
women it is 5.7% whereas HbA1c>8.8% is suggestive of GDM.  Level is reduced 
significantly in patients with anemia.  It yields false positive results in 41% and 
false negative in 26%(20). 
Limitations  
1) It cannot be used for day to day control (Irwin) 
2) It cannot register hypoglycemia (Irwin) 
Advantages 
1. In pregestational diabetes, to know the retrospective blood glucose control 
at the time of conception. 
2. Monitoring the control of glucose in  established diabetic pregnancy. 
b) Glycosylated Albumin 
Glycosylatd albumin has a shorter half life than HbA1c and may be more 
effective in identifying women with an acute rise in mean day blood glucose. 
It reflects the blood glucose status over the preceding 1-3 weeks (Kennedy 
et al 1984). 
8) FRUCTOSAMINE 
Glucose condenses non enzymaticaly with the terminal aminogroup of 
serum proteins to form an unstable aldamine. This undergoes an Amodori 
rearrangement to form more stable ketoamine. This is termed fructosamine 
because of structural similarity to fructose. It assesses the short term state of 
glycemic control over the past 2 weeks(7).  In study by Roberts et al(21) it was 
concluded that  Fructosamine has a sensitive of 50%.  Hence it is not an useful 
screening test. 
DIAGNOSTIC TEST 
Various diagnostic test for GDM are : 
1) O-Sullivan And Mahan’s OG TT Test 
2) WHO 75 gm OG TT 
3) Intravenous Glucose Tolerance Test  
1) O-SULLIVAN AND MAHAN OG TT TEST 
This test served as a gold standard for the diagnosis of gestational diabetes 
mellitus.  In O Sullivan Studies whole blood was tested using the O Somogyi 
Nelson method which measured reducing substances also.  Plasma glucose values 
is 14% higher than those in whole blood obtained from the same sample using the 
same assay method.  NDDG reinterpreted O Sullivan’s data by glucose oxidase 
method on plasma by increasing  O’Sullivan’s criteria by 15%.  This criteria 
reaffirmed by ADA in 1985 stated that the glucose oxidiase method is specific for 
glucose and generally result in 5mg /dl decrease in measured values (Carpenter 
and Coustan).(23) 
The test should be made in the morning after an overnight fast of 8 hours 
after 3 days of normal diet  and physical activity. The subject should remain 
seated and not stand or smoke  throughout the test. 
DIAGNOSTIC CRITERIAS FOR GDM 
 
 Glucose 
Load 
 Fasting 
(mg%) 
1 hr 
(mg%) 
2 hr 
(mg%) 
3 hr 
(mg%) 
O Sullivan and 
Mahan(56) 
100gm Whole 
blood 
90 165 145 125 
Carpenter & 
Coustan(58) 
100gm Plasma 95 180 155 140 
NDDG(57) 100gm Plasma 105 190 165 145 
Langer et al 100gm Plasma 105 190 165 145 
Sacks 75gm Plasma 95 180 155 - 
 
When two values are met or exceeded then a positive diagnosis is made.  
2)WHO 75 gm OG TT  
In many parts of the world(63) 2 hour 75 gm OGTT is used during 
pregnancy. Criteria adopted by WHO for diagnosing GDM is shown in the table 
below. 
 Fasting 2 hrs PPG 
IGT < 126 140-200 
DM > 126 > 200 
 
If the abnormal 2 hour value is 140-200 mg% it is called impaired glucose 
tolerance. The impaired glucose tolerance by WHO in pregnancy is GDM. 
Metzger et al reported that fasting blood glucose after an over night fast 
was approximately 10mg% low in pregnant than in non pregnant level. So fasting 
plasma glucose is not diagnostic of GDM. This one step procedure of diagnosing 
GDM using WHO OGTT serves dual purpose of both screening and diagnosing 
GDM(22). WHO OGTT in pregnancy uses the same threshold as in non pregnant 
individuals. 
Advantages: 
1) Load on the lab is reduced, since number of blood samples drawn are 
reduced 
2) Patient’s compliance is increased 
Disadvantages: 
It requires patient to be in the fasting state. 
3) INTRAVENOUS GLUCOSE TOLERANCE TEST  
This test was adopted for use in pregnancy by Silverstone et al (24,25).  
Intravenous glucose is given at the dose of 0.5g/kg as 25% or 50% solution and 
blood glucose is estimated every 10 minutes for a period of 60 minutes.  The unit 
of measurement of the test, the K value is a measure of the percentage decrease of 
glucose over time, K = 70 (1/2) t. 
Criteria for selection by Silverstone (24) 
Subjects with normal fasting blood sugar, free of glucosuria without any 
family history of diabetes, history of macrosomia, liver disease, cardiac disease or 
hypertension.  They were not on any drugs that affect the glucose tolerance.   
If K value is < 1.5 in pregnant women, it means that she is diabetic. 
None has performed the test in a large group of population and none has 
related the test results to perinatal morbidity. 
Advantages 
1) Unaffected by variation in gastric emptying 
2) It is useful when one vomits with oral test. 
Disadvantages 
1) More expensive 
2) Not subjected  to the normal influence of gastrointestinal physiology. 
Screening Strategy for Gestational Diabetes Mellitus 
In Fourth(3) International Workshop conference for diabetes 
recommendations were made for selective screening based on risk assessment. 
Blood glucose testing is not required in low risk.  In women with average 
risk blood glucose testing is done at 24-28 weeks.  In high risk patients blood 
glucose is tested as soon as feasible and if it is negative the test is repeated again 
at 24-28 weeks and again in the III trimester. 
High Risk : 
1) Member of ethnic group with high prevalence of diabetes. 
2) Age more than 25 years 
3) Known diabetes in first degree relative 
4) Weight abnormal before pregnancy 
5) History of abnormal glucose metabolism. 
6) History of poor obstetric outcome. 
Low risk   
If all the above risk factors are absent. 
Average Risk 
Women of Hispanic, African,Native American,South or East Asian 
Origin. 
Blood glucose testing is done as 2 step procedure.First 50g oral glucose 
challenge test is followed by diagnostic 100gm oral  glucose  tolerance  test , if 
the results exceed a predetermined plasma glucose concentration. It can be done 
as a single step procedure also. 
For a large population where the prevalence of GDM is high, universal 
screening for GDM is required.  When both oral glucose challenge test and 
diagnostic OGTT for GDM has to be done for the huge population   
i) It will be cumbersome 
ii) The phenomenon of no show will be there 
iii) Load on the lab  will be more 
iv) Cost of the test will be high 
Ideal diagnostic test must be cheap, reproducible and have high 
specificity.  Pregnant women often experience nausea while in the fasting state.  
They have to travel to the clinic and wait an additional 2 hr before eating. WHO 
OGCT uses the same glucose load and has the same cut off  value as WHO  
OGTT. WHO OGCT  has the advantage of patient coming in any feeding state 
and it can be done on the same day when the patients report to the antenatal 
clinic.  Hence why WHO OGCT  with the above said  advantages  can’t  be  
used  as  a  diagnostic  test  for  GDM ? 
  
 
AIM OF THE STUDY 
¾ To find out whether 2 hours 75g WHO OG CT is as efficacious as 2 hours 75g 
WHO OGTT  in detecting gestational diabetes mellitus in antenatal population 
between 16 – 32 weeks. 
¾ To analyse fetal  outcome in GDM patients. 
 
MATERIALS AND METHODS 
 
Place of Study  :  Institute of Obstetrics and Gynaecology,  
Egmore. 
 
Year of Study  : 2005 – 2006. 
 
Nature of Study : Prospective  Study 
 
Selection of Cases : 800 pregnant women between 16 – 32 weeks 
    were randomly Selected irrespective of  
parity, age Previous obstetric outcome. 
 
Inclusion Criteria : 
1. All the women with gestational age by history and clinical examination 
between 16 to 32 weeks were included in this study.  
2. Women who were not sure of the last menstrual period and whose clinical 
examination was inappropriate had an ultrasound examination and when the 
period of gestation was between 16 – 32 weeks were included in this study. 
Exclusion Criteria : 
1. Women who were not within 16-32 weeks of gestation were excluded 
from the study. 
2. Women who were already pregestational diabetes were excluded. 
Method  
Pregnant women who were selected with the above criteria had  urine 
glucose and albumin estimation done.Complete and careful clinical history was 
taken with regard to menstrual cycles, previous obstetric history, family history. 
Complete clinical examination was done.  Ultrasound examination was done to 
ruleout congenital anomalies, to detect  hydramnios and macrosomia.  Patients 
were subjected to WHO OGCT .75g glucose was given in 200ml of water.  2 hour 
later 1 cc of venous blood  was drawn in a test tube containing EDTA and 
immediately sample was taken for plasma glucose analysis. Following the glucose 
drink patients were prohibited from eating food or drinking except water. 
Same patients were instructed  to come 2 days later after regular diet 
consumption with over night fasting of 8 hours and 2 hrs 75g WHO OGTT was 
done. The sensitivity and specificity of WHO OGCT in diagnosing GDM is 
estimated by  statistical analysis of plasma glucose values. 
Plasma glucose was estimated by enzyme method in our hospital.  The 
method used in our hospital is described below : 
ENZYME METHOD  
To 20μl of plasma 2ml of the reagent containing glucose oxidase is added 
and kept in an incubator at 37oC for 15-20 minutes. The final colour   developed in 
this test sample is compared with the colour developed in the standard sample 
assayed by the same method in calorimeter at 520nms.  The plasma glucose value 
is determined by the intensity of the red colour developed by comparing with the 
standard sample. 
Chemical Reaction  
Glucose is oxidized by glucose oxidase into gluconic acid and H2O2.  
H2O2 in the presence of peroxidase oxidises  the 4 amino phenazene and phenolic  
compound to a red coloured compound.     
 
Glucose + O2    GOD    gluconic acid + H2O2 
 
H2O2 + Phenolic compound + 4 amino phenazone POD   Red compound + 2H2O 
 
(H2O2 : Hydrogen Peroxide, H2O : Water) 
  
 
RESULTS AND ANALYSIS 
 
Total number of patients screened for gestational diabetes mellitus were 
800.  Out of this, 87 were diagnosed as GDM using WHO criteria.   
 
TABLE – 1 
AGE DISTRIBUTION 
 
Age (yrs) Non-GDM 
Patients 
% GDM 
Patients 
% 
17-20 96 13.46 Nil Nil 
21-25 140 19.63 11 12.64 
26.30 373 52,31 36 41.37 
31-35 81 11.36 31 35.63 
36-40 23 3.26 9 10.34 
41.37% of GDM patients were in the age group of 26-30 years.  
 
 
TABLE – 2 
AGE 
Age Total Patients GDM Patients % 
17-20 96 Nil Nil 
21-25 151 11 7.28 
26.-30 409 36 8.8 
31-35 112 31 27.68 
36-40 32 9 28.13 
 
As age advances the prevalence of GDM increases in our sudy. 
Mean + SD in GDM group = 32.50575 +  2.555767. 
Mean + SD in non GDM group = 26.59327 + 4.125157 
P = 0.0 significant 
There exist a statistically significant difference in age between GDM and Non 
GDM  group. 
 
 
TABLE – 3 (a) 
GRAVIDA 
 
Gravida Non-GDM 
patients 
% GDM 
Patients 
% 
G1 401 56.24 31 35.63 
G2 191 26.79 26 29.88 
G3 90 12.62 19 21.83 
G4 26 3.65 10 11.49 
G5 3 0.42 1 1.15 
G6 2 0.28 Nil Nil 
 
35.63% of GDM patients  were found to be primis. 
 
Table –  3(b) 
 
Gravida Total Patients GDM Patients % 
G1 432 31 7.18 
G2 217 26 11.98 
G3 109 19 17.43 
G4 36 10 27.78 
G5 4 1 25 
G6 2 Nil Nil 
 
As the number of gravida increases the prevalence of GDM increases.  (p 
= 0.0) significant. 
TABLE – 4 
EDUCATIONAL STATUS 
 
Educational 
Status 
Non-GDM 
Patients 
% GDM 
Patients 
% 
Illiterate 273 38.29 20 22.99 
Primary 
Education 
186 26.08 21 24.14 
High School 
Education 
195 27.34 33 37.93 
College 
Education 
59 8.27 13 14.94 
 
37.93% of GDM patients had high school education in our study. 
 
 
TABLE – 5 
SOCIOECONOMIC STATUS 
 
Socioeconomic 
Status 
Non-GDM 
Patients 
% GDM 
Patients 
% 
I Nil Nil Nil Nil 
II 9 1.26 6 6.9 
III 104 14.59 19 21.84 
IV 272 38.15 27 31.03 
V 318 44.6 35 40.23 
 
In our study 35 GDM patients belonged to grade V socioeconomic status 
and 27 GDM patients belonged to Grade IV socioeconomic status.. 
 
TABLE – 6 (a) 
BMI 
 
BMI Non-GDM 
Patients 
% GDM 
Patients 
% 
< 20 48 6.73 5 5.74 
21-24 446 22.55 21 24.13 
25- 29 140 19.63 34 39.08 
> 30 79 11.08 27 31.03 
 
In our study BMI < 20 was seen in 5.74% of GDM patients and BMI > 
30(obese) was seen in 31.03% of GDM patients. 
 
TABLE –  6 (b) 
 
BMI Total Patients GDM Patients % 
< 20 53 5 9.43 
21-24 467 21 4.5 
25- 29 174 34 19.5 
> 30 106 27 25.47 
 
The incidence of GDM in BMI > 30 was 25.47%. (p = 0.0 significant) 
 
 
 
 
TABLE – 7 (a) 
FAMILY HISTORY 
 
 
Family 
History 
Non GDM 
Patients 
% GDM 
Patients 
% 
Positive  101 14.17 44 50.57 
Negative 612 85.83 43 49.43 
 
50.57% of GDM patients had positive family history of diabetes mellitus 
in our study. 
 
 
 
TABLE –  7 (b) 
 
Family History Total Patient GDM Patients % 
Positive 101 44 43.56 
Negative 612 43 7.02 
 
Incidence of GDM in patients with positive family history of diabetes was 
43.56%. (p = 0.0 significant). 
TABLE – 8 
GESTATIONAL AGE AT TESTING 
 
G.A.  at 
Testing 
Non GDM 
Patients 
% GDM 
Patients 
% 
16-20 wks 100 14.02 7 8.05 
21-24 wks 154 21.6 17 19.54 
25-28 wks 196 27.49 49 56.32 
29-32 wks 265 35.48 14 16.09 
 
Out of 87 patients 7 patients were diagnosed between 16-20 weeks, 17 
patients were diagnosed between 21-24 weeks, 49 patients were diagnosed 
between 25-28 weeks, 14 patients were diagnosed between 29-32 weeks. Out of 
100 patients in non GDM group in 16-20 weeks 51 reported for assessment of 
plasma glucose at 24-28 weeks and 30 reported for assessment of plasma glucose 
at 32 weeks and were found to be negative.  Out of 154 patients in non GDM 
group  in 21-24 weeks 100 reported for assessment at 28 weeks (Out of 100, 2 
were found to be positive )and 57 reported for assessment at 32 weeks.  Out of 
196 patients who were negative at 24-28 weeks, 97 came for assessment at 32 
weeks and were negative.  (p = 0.0 significant) 
 
TABLE – 9 
RISK FACTORS IN PREVIOUS PREGNANCY 
 
Risk factors Non 
GDM 
patients 
% GDM 
Patients 
% 
H/o Spontaneous abortion 72 14.72 20 22.99 
H/o. Macrosomic baby 15 2.1 8 9.2 
H/o. Sudden IUD 16 2.24% 5 5.75 
H/o. unexplained still birth 18 2.52 7 8.04 
H/o. unexplained neonatal 
death 
9 1.26 5 5.75 
H/o GDM 6 0.841 2 2.3 
H/o PIH 35 4.91 6 6.89 
H/o Congenital Anomalies 3 0.42 4 4.6 
 
Among GDM patients 20 had history of spontaneous abortion, 8 had 
history of delivery of  macrosomic baby, 5 had sudden IUD, 7 had history of 
unexplained neonatal death, 2 had history of GDM, 6 had history of PIH and 4 
had history of babies with congenital anomalies (4VSD, 1 anencephaly, 1 
meningocele) in previous pregnancies. 
 
TABLE – 10 
RISK FACTORS IN PRESENT PREGNANCY 
 
Risk factors Non GDM 
Patients 
% GDM 
Patients 
% 
Obesity 79 11.08 27 31.03 
Recurrent UTI 20 2.81 11 12.64 
Moniliasis 17 2.38 23 26.44 
PIH 51 7.15 14 16.09 
Hydramnios 11 1.54 2 2.3 
Glycosuria 83 11.64 9 10.34 
Cong. Malformation 8 1.12 1 1.15 
Macrosomia 36 5.89 18 20.69 
 
Among GDM patients 27 were obese, 11 had history of recurrent UTI, 23 
had history of moniliasis, 14 had history of PIH, 2 had hydramnios, 9 had 
glycosuria, 1 had congenital anomaly (VSD) and 18 had macrosomia.  
TABLE – 11 
PLASMA GLUCOSE 
 
Plasma 
Glucose 
WHO OGTT % WHO OGCT % 
61-70 63 7.88 59 7.38 
71-80 71 8.88 70 8.75 
81-90 103 12.88 108 13.5 
91-100 116 14.5 120 15.75 
101-110 140 17.5 130 16.25 
111-120 95 11.88 98 12.25 
121-130 97 12.13 99 12.38 
131-139 28 3.5 29 3.63 
140-150 21 2.63 24 3 
151-160 22 2.75 18 2.3 
161-170 19 2.38 22 2.75 
171-180 14 1.75 13 1.63 
181-190 11 1.38 10 1.25 
 
The prevalence of GDM in our study was 10.89%.  Al the patients who 
were diagnosed as GDM by WHO OGTT had positive values by WHO OGCT 
also 
.   
Mean + SD of plasma glucose values  
GDM Non-GDM P value  
WHO OGTT 162.0805+ 
13.01271 
99.26648 + 
13.01271 
0.0 significant 
WHO OGCT 162.03482 + 
13.03482 
99.90182 + 
20.20579 
0.0 significant 
 
Positive patients were referred to pregnancy diabetic service of IOG for 
treatment of GDM and followed up until delivery. 
Out of 87 GDM patients only 65 patients came for delivery at IOG.  Fetal 
outcome were assessed for these patients.  
 
 
 
TABLE – 12 
 
MODE OF DELIVERY  
 
Mode of delivery GDM Patients % 
Normal 24 36.92% 
Assisted Vaginal 9 13.84% 
Caesarean section 32 49.23% 
 
Babies were delivered by caesarean section in 49.23% of GDM patients.   
 
 
FETAL OUTCOME OF GDM PATIENTS 
 
TABLE – 13 (a) 
GESTATIONAL AGE AT DELIVERY 
 
Gestational Age at 
Delivery 
GDM Patients % 
Preterm 9 13.85% 
Term  56 86.15% 
 
Preterm delivery was seen in 13.85% of GDM patients and term delivery 
was seen in  86.15% of GDM patients.  
 
TABLE – 13 (b) 
BIRTH WEIGHT 
  
Birth Weight (kg) GDM patients % 
2 – 2.4 5 7.69 
2.5 – 2.9 12 18.46 
3 – 3.4 18 27.69 
3.5 –  3.9 14 21.54 
>   4  16 24.61 
 
Macrosomia defined as birth weight  > 4kg was seen in 24.61% of GDM 
pregnancies delivered at IOG. 
 
TABLE – 13 (c) 
APGAR SCORE 
 
Apgar Score GDM Patients % 
8 and above 51 78.46% 
5 – 7 11 16.92% 
1 – 4 3 4.61% 
 
Apgar score of 8 and above was seen in 78.46% of GDM patients in our 
study.  Apgar score of 5-7 was seen in 16.92% of GDM patients,  
 
TABLE – 13 (d) 
NEONATAL COMPLICATIONS 
 
Neonatal Complications GDM Patients % 
Hypoglycemia 19 29.23% 
Hypocalcemia 13 20% 
Hyperbilirubinemia 10 15.38% 
Congenital Anomalies 1 1.54% 
RDS 6 9.2% 
 
Hypoglycemia was seen in 29.23%, hypocalcemia was seen in 20% and 
RDS in 9.2% of infants of GDM. 
 
PERINATAL MORTALITY 
All the women with GDM who delivered at IOG had good fetal outcome.  
Even the babies who had complications recovered well.  
 
DISCUSSION 
A prospective study was conducted in IOG during 2005- 2006. For this 
study 800 randomly selected  pregnant women in 16- 32 weeks of gestation were 
included.  2 hour 75g WHO OGCT  and 2 hr 75g WHO OGTT were estimated in 
all these women. This study was designed to find out whether 2 hr 75g  WHO 
OGCT is as effective as 2 hr 75g WHO OGTT in diagnosing GDM. 
PREVALENCE 
According to Beischer et al 1991, the prevalence of GDM in Indian 
subcontinent is 15%. 
In a study conducted at Jean Verdier Hospital, France  it was identified 
that prevalence of GDM was 15.65% , if universal screening method is 
adopted(28). 
In a study conducted by Dr. Anjalakshi for evaluation of diagnostic 
criteria for AGT in South Indian Pregnant women prevalence of  GDM was found 
to be 15% (26). 
Seshiah et al found the prevalence of GDM to be 16.2% in India in his 
study using WHO Criteria(22).  Schmidt et al in 2001 found out the incidence of 
GDM to be 7.2% by WHO criteria(27). 
In our study prevalence of GDM  by WHO criteria was 10.89%. 
PREVALENCE OF GDM 
Study Prevalence 
Beischer et al 15% 
Benchimol et al 15.65% 
Dr. Anjalakshi 15% 
Seshiah et al 16.2% 
Schmidt et al 7.2% 
Our Study 10.89% 
 
WHO OGTT  
Seshiah et al found that out of 891 pregnant women who underwent 50g 
GCT and a subsequent 75g OGTT 144 had GDM by WHO criteria.  Out of these 
144 cases only 113 had initial 50g value > 130 mg/dl. So diagnosis of GDM by 
OGTT based on initial GCT screening leaves 21.3% undiagnosed. The two step 
procedure is not practical as patients have a phenomenon of no show and number 
of blood samples are more thus increasing the  load on the lab. So it is ideal to go 
for WHO OGTT which detects more cases of GDM, reduces load on the lab, 
improves the patients compliance(22).  In the present study those who had normal 
OGTT in the earlier pregnancy were asked to review later for reassessment of 
plasma glucose by WHO criteria and there was a phenomenon of no show in these 
patients when they were asked to come later for reassessment of plasma glucose 
similar to Prof. V. Seshiah’s study.  
Schmidt et al compared ADA criteria and WHO  criteria and found that 
among 4877 women studied, 2.4% presented with GDM by ADA criteria and 
7.2% by WHO criteria. GDM by WHO predicts an increased risk of macrosomia, 
preeclampsia and perinatal death(27).  
Benchimol et al in his study at Jean Verdier hospital used one step WHO 
OGTT and found the prevalence of GDM to be 15.65%(28). 
To standardize the diagnosis of GDM WHO has proposed using a 2 hour 
75 g OGTT with a threshold plasma glucose concentration greater than 
7.8mmol/lt at 120 minutes. These criteria identify two to three times more women 
as having GDM than American methods(29). Prevalence of GDM in our present 
study is 10.89%. 
In HAPO study which is a 5 years prospective observational study 
recruiting 25000 pregnant women in 10 countries uses 2 hrs 75g OGTT  using 
WHO criteria.  One can understand the importance of WHO OGTT in diagnosing 
GDM and predicting adverse pregnancy outcome when such a large study adopts 
the WHO criteria(30).  In our study also we have used WHO criteria for diagnosing 
GDM. 
Since all the above studies use WHO  OGTT for diagnosing GDM and 
have detected a large number of cases, WHO OGTT was used as a gold standard 
for comparing WHO OGCT. 
WHO OGTT Vs WHO OGCT 
A study was done by David J Petitt by comparing the one step WHO 
OGCT and NDDG criteria. He showed that the subjects who were positive by 
NDDG criteria were also positive by WHO OGCT and it identifies more cases 
which were considered normal by NDDG criteria31. 
There is  strong argument for not requiring an overnight fast before the 
initial glucose tolerance test.  Pregnant women often experience nausea when 
fasting and may refuse or be unable to fast until the test.  It may be impossible for 
the women to getup, travel to the clinic and then wait an additional 2 hrs before 
eating.  Because glucose concentration during the oral glucose tolerance test is 
affected little by the time since the last meal (32), fasting adds very little to the 
glucose tolerance test making the test more cumbersome.  The nonfasting 2 hrs 
post 75g glucose concentration strongly predicts adverse outcome for the mother 
and off spring. O’ Sullivan and Mahan’s OGTT predicts the development of 
diabetes in the mother later on and it doesn’t give the fetal outcome.  But WHO 
criteria which is used in our study predicts both maternal and fetal outcomes.  
In our study WHO OGCT was done in 800 cases on whom WHO OGTT 
was also done.  It  was found that all patients who were detected to have GDM by 
WHO OGTT were also positive by WHO OGCT. Hence in our  study it is shown 
that WHO OGCT is as efficacious as WHO OGTT in diagnosing GDM.  WHO 
OGCT also predicts adverse maternal and fetal outcomes. 
A study was done by Dr. Anjalakshi on abnormalities of glucose 
intolerance in pregnant women by comparing WHO OGCT with WHO OGTT.  
Sensitivity and specificity was found to be 0% and 84% respectively.  This was in 
contrast to our study which showed sensitivity and specificity of 100%. 
 Sensitivity Specificity 
Dr. Anjalakshi   0% 84% 
Our Study          100% 100% 
 
In our study WHO OGCT is as efficacious as WHO OGTT in detecting 
GDM.  More studies are needed before its clinical application can be made to 
diagnose GDM. 
STATISTICAL DATA 
 WHO OGTT 
 + - 
               WHO             +  87 a 
0 
b 
               OGCT             -   0 c 
713 
d 
 
Sensitivity  =  87  x 100 = 100% 
   87 
 
Specificity  = 713   x 100 = 100% 
  713 
  
MATERNAL OUTCOME 
 
AGE :  
 
Age Total Patients GDM Patients % 
17-20 96 Nil Nil 
21-25 151 11 7.28 
26.-30 409 36 8.8 
31-35 112 31 27.68 
36-40 32 9 28.13 
 
Coustan et al(36) found that the incidence of GDM is 3.8% in women of 30 
– 34 years of age but only 0.7 in women younger than 21 in a large study of  
unselected population. 
In our study the incidence of GDM is 27.68% in women of  31-35 years.  
It is found that in our study as age advances prevalence of GDM increases. 
Moses et al(37) found that age more than 30 years was present in 8.5% of 
GDM patients and younger than 21 years was present in 0.7% of GDM patients. 
Seshiah et al(22) in his study in 2005 found that the incidence of GDM in < 
20 years is 14.5%, 20-24 years 13.7%, 25-29 years 19.5%, > 30 years 25%.  It is 
shown that as the age advances prevalence of GDM increases which is 
comparable  to our study.  In our study (p = 0.0) there exists  a statistically 
significant difference in age between the GDM and the non-GDM group. 
GRAVIDA 
Prevalence of Gestiaonal Diabetes increases with gravidity from 16.3% in 
primi to 25.8%  in gravidas > 4 in a study by Seshiah et al(22). 
In our study the prevalence of gestational diabetes increased with gravidity 
from  7.18% in primi to 27.78% in gravida 4. (p = 0.0 and it is statistically 
significant) and it is similar to the finding in Seshiah’s study.  
Pyke De et al found that the incidence of gestational diabetes increases 
with parity(38). 
BMI 
Serirat et al(39) in 1992, in a study found that  obesity was present in 
26.5% of patients with GDM.  In our study BMI > 30 was presenting 31.03% of 
patients with GDM. (p=0.0 and it is statistically significant) 
In a study by Seshiah et al(22) the incidence of GDM was 33.3% in 
patients with BMI > 30.  The incidence of GDM increases as the BMI increases, 
comparable to our study..  

FAMILY HISTORY 
Serirat et al in 1992 has shown that family history of diabetes is present in 
23.1% of patients with abnormal glucose tolerance(39). 
Moses et al has shown that family history of diabetes is present in 11.6% 
of patients with GDM(37). 
In our study  family history of diabetes was present in 50.57% of patients 
with GDM. (p = 0.0) 
PIH 
Suhoven & Terano et al(41) in 1993 reported the incidence of PIH and 
preeclampsia to be 2 times more common among GDM patients than controls.  
(19.8% Vs 10%). 
In a study by Schmidt et al(27), it was found that frequency of preeclampsia 
was 5%  
PIH was seen in 13.7% in GDM in a study by Cousins et a(40)l.  
In our study PIH was present in 16.09% of patients with GDM which was 
equivalent to the finding by Suhoven. 
 Study Incidence of PIH in GDM 
Suhoven et al 19.8% 
Schmidt  et al 5% 
Cousins et al 13.7% 
Our study 16.09% 
 
HYDRAMNIOS 
Rosenn and Combs et al found the incidence of hydramnios to be 26.4% 
in their study(43).  
Biggio et al in 1999 reported that hydramnios occur in 20% of diabetic 
pregnancies. 
In Cousins study Incidence of hydramnios ranges from 2 to 2.1% in GDM 
similar to our study(45). 
Study Incidence of Hydramnios in GDM 
Rosenn et al 26.4% 
Cousins et al 2-2.1% 
Our study 2.3% 
 
GESTATIONAL AGE AT TESTING 
A study was done by Seshiah et al for detection of GDM in the three 
trimester of pregnancy.  Among the studied patients 16.3% were within 16 weeks 
of gestation, 23.1% were between 17-23 weeks, 60.6% were more than 24 
weeks(64).  
In our study involving screening and diagnosing GDM in antenatal 
population between 16-32 weeks, 27.59% of GDM patients were between 16-24 
weeks and 72.41% of GDM  patients were between 25-32 weeks. 
MATERNAL MORTALITY 
Maternal deaths have become rare in women with diabetes although as 
emphasized by Cousins  who stated that mortality is increased 10 folds most often 
as a result of ketoacidosis, hypertension, preeclampsia, pyelonephritis and patients 
with coronary artery disease. 
In our study there was no maternal mortality. 
FETAL OUTCOME 
Birth Weight 
Spellacy, WN Miller, S. Winegar found that Macrosomia was present in 
50% of pregnant patients with GDM(50). 
In our study macrosomia was seen in 20.69% of pregnant patient with 
GDM. 
Langer et al also found 50% of pregnant patient with GDM to have 
macrosomia(51). 
NEONATAL COMPLICATIONS 
Hypoglycemia 
Cowett et al found that infants of women with GDM have an incidence of 
neonatal hypoglycemia that approaches 30-50%(53). 
According to James the frequency of hypoglycemia is 18-49%(52).  
Hypoglycemia was seen in 29.23% of infants of GDM in the present study.  This 
was same as the above studies.  
 
Study Incidence of hypoglycemia in infants 
of GDM 
Cowett et al 30-50% 
Our Study 29.23% 
 
HYPOCALCEMIA 
Hypocalcemia defined as total serum calcium level less than 7mg/dl 
affects 50% of infants with GDM (Marshall et al)(54)  
In our study hypocalcemia was seen in 20% of infants with GDM. 
HYPERBILIRUBINEMIA 
Tyrala et al states that hyperbilirubinemia defined by serum bilirubin level 
> 13mg/dl  was seen in 20% of GDM pregnancies(60). 
Hyperbilirubinemia was present in 15.38% of GDM pregnancies in our 
study which was comparable similar to  Tyrala et al study. 
Study Hyperbilirubinemia %  in infants of 
GDM 
Tyrala et al 20% 
Our Study 15.38% 
 
RESPIRATORY DISTRESS SYNDROME 
Robert et al found that the risk of developing RDS was 5.67% in  infants 
of GDM mothers(61).   
In our study RDS was present in 9.2% of GDM pregnancies, probably due 
to the high caesarean section in GDM.  
SUMMARY 
1) In 800 Randomly selected patients who attended our antenatal clinic 
prevalence of GDM was found to be 10.89% by WHO criteria. 
2) 2 hr 75g WHO OGCT was performed  on all 800 patients attending our 
antenatal clinic between 16-32 weeks since ethnically Indian belong to a 
high risk group. 
3) Out of 100 non GDM patients between 16-20 weeks only 51 reported 
reassessment at 24-28 weeks and 30 reported for reassessment at 32 
weeks.  Out of 154 non GDM patients at 21-24 weeks, 100 reported for 
reassessment at 24 weeks and 57 reported for reassessment at 32 weeks.  
Out of 196 non GDM patients at 25-28 weeks only 97 came for 
reassessment at 32 weeks.  This demonstrates the phenomenon of no 
show. 
4) In our study it was found that all the patients who were diagnosed as GDM 
by WHO OGTT gave positive results with WHO OGCT.  Thus sensitivity 
and specificity of WHO OGCT is 100%. WHO OGCT is useful as a 
diagnostic test for GDM.  No show is not possible in first visit. 
5) In our study it was found that i) As age increases the prevalence of  GDM 
increases, ii) As number of gravida increases prevalence of GDM 
increases, iii) As BMI increases prevalence of GDM increases, iv) Positive 
family  history predicts the higher risk of developing GDM, v) 
Macrosomia was seen in 20.69% of GDM patients.  
Complications % in GDM Patients 
Hydramnios 2.3% 
PIH 16.09% 
Macrosomia 20.69% 
Caesarean section rate 49.23% 
Hypoglycemia 29.23% 
Hypocalcemia 20% 
Hyperbilirubinemia 15.38% 
RDS 9.2% 
  
Among mothers whose babies had macrosomia 13 were on insulin and 5 
were on medical nutrition therapy. 
6) Hence early detection of gestational diabetes and effective management to 
maintain optimal blood glucose levels will drastically reduce maternal 
morbidity due to gestational diabetes and bring about a definite  reduction 
in perinatal mortality rate. 
CONCLUSION 
1) Screen pregnant women universally for gestational diabetes. 
2) 2 hr 75g WHO OGCT can be used to diagnose GDM and is as efficacious 
as 2 hr 75g WHO OGTT.  More studies are needed before clinical 
application can be made. 
3) To detect Gestational Diabetes Mellitus early. 
4) Inspite of treatment 20.69% of GDM patients had macrosomic babies. In 
infants of GDM patients RDS was seen in 9.2%,  hypoglycemia was seen 
in 29.23%,.  hyperbilirubinemia was seen in 15.38%.  So more stringent 
treatment of GDM will improve perinatal outcome. 
Screening universally for GDM improves the perinatal outcome, 
postpones the onset of diabetes in mother and also has a role in primary 
prevention of diabetes in offspring. 
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PROFORMA 
 
Serial  Number  :      
Name of the Patient:     Husband’s Name : 
Age  :  
OP Number  : 
Address : 
Socioeconomic Status : 
Educational Qualification of  mother : 
 
OBSTETRIC FORMULA 
 Gravida Parity Living Abortion 
 
 
 
 
 
 
    
LMP :     EDD : 
Marital Status : 
FAMILY HISTORY  
Diabetes : Yes / No 
Hypertension :  Yes / No 
GESTATIONAL AGE IN WEEKS AT THE TIME OF TESTING  
H/O RISK FACTORS :   
IN THE PRESENT PREGNANCY  :  
Age more than 25 years  
Obesity  
H/o. Recurrent UTI  
History of Moniliasis  
PIH  
Hydramnios  
Glycosuria  
Congenital malformations  
IN THE PAST PREGNANCIES  
H/o. Spontaneous  Abortions  
H/o. unexplained neonatal death  
H/o. sudden IUD  
H/o. Unexplained still birth  
H/o. Macrosomia  
H/o. GDM  
H/o. PIH  
H/o. Congenital anomalies  
 
GENERAL EXAMINATION 
 
Anaemia  : Yes / No 
Pedal Oedema : Yes / No 
Pulse Rate  :  
Blood Pressure : 
Height   :    Weight : 
Pre-pregnancy weight : 
BMI (Calculated from prepregnancy weight) 
CLINICAL  EXAMINATION  
Gestational Age 
Investigations  
Urine :  Albumin :   Sugar : 
Blood  
Haemoglobin  
PCV 
 
DATE OF SCREENING    
Gestational Age at 
screening 
   
2 hr 75g WHO OGCT    
2 hr 75g WHO OGTT    
 
USG FINDINGS 
OUT COME OF  PRESENT PREGNANCY 
Mode of delivery   
Date of delivery   
Gestational Age At 
Delivery 
  
Birth Weight   
Apgar score :  
 
NEONATAL COMPLICATIONS 
Hypoglycemia   
Hypocalcemia   
Hyperbilirubinemia   
Congenital Anomaly   
RDS   
 
ABBREVIATIONS 
ADA : American Diabetes Association 
AGT : Abnormal Glucose Tolerance 
BMI : Body Mass Index 
BW : Birth Weight 
DM : Diabetes Mellitus 
EDTA : Ethylene Diamine Tetra Acetic Acid  
FPG : Fasting Plasma Glucose 
G.A : Gestational Age 
GDM : Gestational Diabetes Mellitus 
GOD : Glucose Oxidase  
GTT : Glucose Tolerance Test 
HAPO : Hyperglycemia Adverse Pregnancy Outcome 
Hb : Hemoglobin 
IGT : Impaired Glucose Tolerance 
IOG : Institute Of  Obstetrics And Gynecology 
IQ : Intelligent Quotient 
IUD : Intra Uterine Death 
NDDG : National Diabetes Data Group 
NonGDM : Non Gestational Diabetes Mellitus 
OGCT : Oral Glucose Challenge Test 
OGTT : Oral Glucose Tolerance Test 
PCV : Packed Cell Volume 
PIH : Pregnancy Induced  Hypertension 
POD : Peroxidase 
PPG : Post Plasma Glucose 
RDS : Respiratory Distress Syndrome 
SD : Standard Deviation 
SE Status : Socio Economic  Status 
UTI : Urinary Tract Infection 
VSD : Ventricular Septal Defect 
WHO : World Health Organisation 
     
 
KEY TO MASTER CHART 
Age  
17-20 years - 1 
21-25 years - 2 
26-30 years - 3 
31-35 years - 4 
36 - 40 years - 5 
 
Socio Economic Status  
Class I - A 
Class II - B 
Class III - C 
Class IV - D 
Class V - E 
 
BMI 
<  20 - A 
21– 24 - B 
25 - 29 - C 
> 30 - D 
 
FAMILY HISTORY 
Positive - + 
Negative - - 
 

GESTATIONAL AGE AT TESTING 
16-20 weeks - 1 
21-24 weeks - 2 
25-28 weeks - 3 
29-32 weeks - 4 
 
OBSTETRICS CODE 
G1(Gravida  1)  - I 
G2 (Gravida 2) - II 
G3(Gravida  3) - III 
G4 (Gravida 4) - IV 
G5 (Gravida 5) - V 
G6 (Gravida 6) - VI 
 
RISK FACTORS IN PREVIOUS PREGNANCY 
Spontaneous Abortion - SA 
Macrosomia     - M 
Sudden Intrauterine Death  - SID 
Unexplained Still Birth  - USB 
Unexplained Neonatal Death - UND 
History of GDM    - HG 
History of PIH   - HP 
Congenital Anomaly  - CA 
 
RISK FACTORS IN PRESENT PREGNANCY -  
Obesity     - OB 
Pregnancy Induced Hypertension - PIH 
Hydramnios      - H 
Glucosuria     - G 
Congenital Anomaly  -  CA 
Macrosomia     - M 
Recurrent UTI    - RU 
Moniliasis     - MON 
GESTATIONAL AGE AT DELIVERY 
Term             - T 
 Preterm      - PT 
BIRTH WEIGHT (Kg) 
2 – 2.4     - A 
2.5 – 2.9     - B 
3 – 3.4     - C 
3.5 – 3.9     - D 
> 4     - E 
 
APGAR SCORE 
8 and above      - A 
5 – 7      - B 
1 – 4     - C 
 
NEONATAL COMPLICATIONS 
Hypoglycemia    - HG 
Hypocalcemia    - HC 
Hyperbilirubinemia   - HB 
Respiratory Distress Sydrome- RDS 
CA     - Congenital Anomaly 
W
H
O
 O
G
 T
T
W
H
O
 O
G
C
T
1 Nalini 5 E III 1 A SA RU 63 74
2 Ragini 3 D I 4 B M,G,PIH 72 65
3 Ilavarasi 1 E + I 3 B 95 96
4 Jayanthi 2 C II 2 B PIH G 102 106
5 Sathya 5 D III 3 B PIH 62 65
6 Priya 3 C I 1 B 86 95
7 Sridevi 1 E I 1 B H 95 86
8 Ramya 2 B + II 2 D Ob,PIH 112 114
9 Neelavathi 3 E I 3 C 65 64
10 Nandhini 3 D II 1 B 73 76
11 Shayeen 3 C I 3 D OB 115 117
12 Kanimozhi 3 E II 2 B G,M 96 85
13 Lakshmi 4 E III 3 C UND 134 128
14 Radhika 3 C + I 3 B G 96 87
15 Devi 3 E IV 2 C 68 63
16 Margaret 3 D II 2 B PIH 76 74
17 Revathi 3 E I 1 B 106 107
18 Mumtaj 3 C + I 4 A 95 93
19 Logeshwari 3 D III 2 B USB M 116 109
20 Vanitha 2 D I 3 C 109 116
21 Tulasi 3 D + III 1 B 74 76
22 Gajalakshmi 1 E I 2 B 87 89
23 Anandhi 3 C II 1 A PIH G 96 95
24 Fathima 4 D III 3 B SA PIH 66 65
25 maheshwari 3 E + I 3 B 74 76
26 Vijayalakshmi 2 E I 2 D OB 106 108
27 Gomathi 3 D III 1 B G 94 96
28 Shanthi 2 E I 4 B RU 116 108
29 Selvi 3 E I 3 B 65 67
30 Sripriya 2 D III 4 B SID 96 95
31 Jothi 3 E I 1 C 91 95
32 Rama 3 D + II 4 D PIH OB 116 106
33 Nabeesa 2 C I 2 B 95 98
34 Raji 3 E I 3 B 76 84
35 Megala 4 C II 4 B UND G 83 72
36 Rajam 1 E I 2 B 65 67
37 Melisna 3 E II 1 B 106 116
38 Dhakshayini 5 C + II 3 B 105 109
39 Venkatapriya 2 E I 3 C PIH 94 97
40 Latha 3 D I 1 A 74 77
41 Kalaivani 4 E II 2 B SID M 107 109
42 Mohana 3 E IV 4 B SA,M 116 118
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43 Anitha 3 D I 4 B 106 105
44 Priya 3 D I 2 C 116 112
45 Nirmala 1 D I 1 B 106 105
46 Jeslin 4 E III 2 B 86 79
47 kala 2 D + I 4 B 78 84
48 Sumati 3 C II 4 D M OB 116 118
49 Sadhana 4 D II 1 A G 94 92
50 Indira 4 E I 3 B 106 109
51 Jesintha 1 D I 2 B 64 68
52 Subha 1 E I 4 B 86 78
53 Gantha 4 D II 4 D OB,PIH 124 118
54 Bindhu 2 C I 4 B 76 84
55 Amitha 3 E II 3 B G 116 124
56 Govindammal 1 C + I 2 B 106 94
57 Reema 3 D II 4 B USB 94 108
58 Jamila begum 2 C I 3 B 116 112
59 Farhana 3 E I 3 B RU 112 118
60 Amudha 3 D I 4 D OB 132 136
61 Lakshmi 2 D I 4 B G 106 108
62 Trisha 3 E I 4 B 84 82
63 Renuka 3 D III 4 D SA OB 124 116
64 Misha 3 E I 1 B 126 126
65 Gowri 4 D II 4 B MON 116 106
66 Nirupama 2 E I 3 B 104 116
67 Sarala 1 E I 4 B 96 88
68 Meenakshi 3 D I 3 B 84 88
69 Rose 3 C I 4 B MON 124 109
70 Jayakumari 3 E I 2 B 106 121
71 Rasiya begum 3 D + I 4 C PIH 122 126
72 Padmini 4 E II 4 A PIH G 84 86
73 Guna 2 D I 4 C 121 134
74 Jothiswari 3 E + I 4 C G 104 106
75 Banumathi 3 D II 4 D OB 134 128
76 Vijaya 1 D I 2 B M 124 128
77 Lekha 3 E III 3 B 84 85
78 Rajakumari 3 E II 4 B SID 106 86
79 Vasantha 3 D IV 4 B 124 126
80 Aysha 2 C III 3 B SA 84 94
81 Velankanni 3 E I 4 C 94 98
82 Shajith bee 1 D I 2 C 102 101
83 Bharathi 3 E II 3 D PIH OB 124 126
84 Punitha 2 D I 3 B 84 83
85 Hema 3 E I 4 C G,H 124 128
86 sangeetha 3 E II 2 B PIH 121 126
87 Nivetha 1 E I 4 B MON 107 94
88 Chithra 4 D + II 4 B 124 129
89 Rani 1 D + I 2 A PIH 68 72
90 Latha 3 C II 1 D SID OB,PIH 94 91
91 Hema 2 E I 3 B G 121 127
92 Meena 1 E II 4 C USB 72 61
93 Saradha 4 D + I 2 B MON 91 95
94 Mari 3 E I 3 D OB 124 125
95 Rama 4 E III 1 B M RU 72 62
96 Vijayalakshmi 2 E I 2 B 124 126
97 Elavarasi 3 D II 4 C UNB 62 72
98 Kamini 3 E I 4 B 106 124
99 Koteeswari 1 E II 3 B HG G 126 121
100 Eswari 3 C + I 2 D OB 116 121
101 Lakshmi 4 D I 1 A 94 96
102 Nithya 2 E I 3 B 61 63
103 Jothilakshmi 3 E II 2 C M 71 74
104 Sandhya 1 E I 3 B 94 97
105 Muneeswari 3 D III 2 B SA 61 63
106 Mahalakshmi 3 E I 4 B 72 61
107 Vidhya 1 C II 1 D OB 106 108
108 Fousia 2 D I 2 B 61 71
109 Parveen 3 E III 3 A SA 94 104
110 Elakiya 4 E + I 1 C G 112 122
111 Dharini 2 D I 2 B 104 96
112 Dhanalakshmi 3 E II 4 D M OB,PIH 124 112
113 Iniya 1 C I 4 B 62 74
114 Ellammal 3 E + I 1 B 112 124
115 Rojarani 3 D II 2 B SID G 67 72
116 Ramani 2 E I 3 C 74 68
117 Rosi 5 E I 4 D OB 84 92
118 Ambika 1 D II 4 B USB 105 101
119 Veena 3 C I 2 B 99 100
120 Menaka 4 E III 1 B SA 80 78
121 Banu 2 D I 3 B 66 67
122 Chamundeeswari 3 E I 4 B 112 124
123 Bindu 3 E I 3 B 112 104
124 Sivasankari 1 E II 3 B PIH 65 76
125 Monisha 2 D I 1 C G 96 94
126 Annalakshmi 4 E IV 2 D SA OB 102 112
127 Bragadi 5 C I 4 B MON 72 68
128 Vishalam 2 E + II 2 B 69 60
129 Durgalakshmi 1 D + I 1 A RU 84 105
130 Malliga 3 E II 4 C PCA 107 88
131 Cicillia 3 D I 3 B PIH 124 127
132 Tharangini 2 E I 2 D OB 122 122
133 Nagammal 3 D II 1 B UND H 67 66
134 Chandra 1 C I 4 C G 129 128
135 Poongodi 3 E II 3 B 94 96
136 Dahlia 2 D I 2 B 88 90
137 Sumathi 1 E I 4 C 104 100
138 Ayyammal 3 E I 3 B 116 110
139 Mala 3 D III 4 B SA 96 112
140 kalaiselvi 3 E II 3 B 106 96
141 Sendamarai 4 D I 1 B 74 74
142 Shanthi 2 C II 2 B PIH G 94 101
143 Anandhi 1 E I 3 D OB 68 74
144 Durga 3 E I 2 A PIH 116 118
145 Thenmozhi 2 D II 1 C MON 84 86
146 Nagabooshanam 4 E + I 3 B 66 69
147 Chellammal 3 E I 2 B H 96 106
148 Duraiammal 5 D + I 4 D OB 124 127
149 Ranjani 1 E III 4 B SA PIH 106 100
150 Neelavathi 4 C I 1 C G 116 124
151 Chellammal 2 E II 2 B PIH 96 94
152 Palaniammal 3 E + I 3 D OB 62 67
153 Deivanai 3 D + IV 2 B SA 126 106
154 Dhanakodi 3 E I 3 B 74 72
155 Mumtaz 3 E I 2 B 104 106
156 Loganayaki 2 D I 4 B 106 116
157 Rajeshwari 3 E I 2 B CA 62 64
158 Pounu 1 D II 1 B 106 88
159 Mayil 2 C I 3 C 94 104
160 Patttammal 3 E I 3 C 86 92
161 Kanniammal 4 E II 2 A 61 64
162 Vijaya 2 D I 4 D OB,PIH 126 116
163 Cauvery 1 E + III 2 B SID G 94 96
164 Poovathal 3 E I 1 B H 74 76
165 Yamuna 5 C II 3 B 112 124
166 Sarojini 3 E I 2 C 94 92
167 Ammu 1 D I 4 B 62 67
168 Lalitha 3 E II 4 A USB G 96 106
169 Gowri 2 E I 2 D OB 104 98
170  Manohari 1 C I 3 B 109 108
171 Dhanam 3 D III 2 C CA 112 116
172 Amulu 4 E I 4 B 94 96
173 Kuppu 2 E II 2 D OB 124 127
174 Glory 3 E I 3 B 68 70
175 Kasiammal 2 E II 4 D OB 94 87
176 Meenammal 1 E I 3 B 86 92
177 Nowshath 3 C + I 3 D OB 116 106
178 Anjalai 4 D II 2 A PIH G 62 71
179 Martha 3 E I 3 C MON 105 112
180 Ranjitha 1 E + III 4 B SA RU 94 96
181 Kotteeswari 2 E I 1 B 74 76
182 Gracy 3 D I 2 D OB 81 85
183 Vanaja 4 E II 3 C UND PIH 112 122
184 Samudhram 2 E + I 4 B G 68 67
185 Alisha 3 C II 1 B PIH 124 112
186 Yesodha 1 E I 3 D OB 94 97
187 Sulochana 4 E IV 4 C M,SA 86 8
188 Gunasundari 3 D I 3 B CA 124 127
189 Shanthakumari 5 E I 4 B 94 101
190 Shalini 2 D I 3 B 106 98
191 Logeshwari 3 D I 4 C 110 114
192 Boomadevi 3 E II 3 B SID 112 109
193 Adhilakshmi 1 D I 2 B G 84 88
194 Kanika 2 C I 3 D OB 94 96
195 Tamilselvi 3 E + II 1 C HG 104 107
196 Devi 4 E I 4 A 67 69
197 Geetha 3 D + I 2 B H 124 116
198 Shankari 1 E I 3 D OB 112 124
199 Chennammal 4 E III 1 B SA 98 90
200 Kanchana 3 E I 4 B 89 97
201 Amsa 2 D II 2 C PCA PIH 79 80
202 Esthermary 3 C + I 3 D OB 124 127
203 Veni 1 E I 4 B 86 87
204 Priya 3 D II 2 B USB 124 122
205 Malar 4 E I 3 B 106 98
206 Godavari 2 D I 4 B 88 8
207 Velankanni 3 E I 3 B 92 101
208 Ruthra 2 E I 3 B 81 91
209 Chinnapappa 3 D II 2 B PIH PIH 106 107
210 Umarani 1 E I 4 B 94 88
211 Mani 2 E I 3 B 61 64
212 Devammal 3 C III 1 A M PIH 121 127
213 Pamila 4 E + I 2 C MON 86 81
214 Ganga 2 D I 3 D OB 110 109
215 Victoria 3 E + II 4 B RU 94 97
216 Rebeccaa 1 D I 1 B G 105 112
217 Kanmani 4 E II 2 A H 124 127
218 Sita 3 D I 3 C 66 69
219 Fathima 2 C + IV 4 B 84 89
220 Jeyamani 3 E I 3 D OB 122 116
221 Meenalochini 1 D I 2 B 76 74
222 Pappa 3 E III 4 B 120 128
223 Sivagami 3 D I 4 B G 94 106
224 Alamelu 3 E I 3 B 108 100
225 Kamala 2 E I 2 A 98 105
226 Selvarani 3 E I 3 C G 90 78
227 Mangai 3 D II 4 D M OB 106 95
228 Jagadha 2 E I 3 B 68 81
229 Kalyanam 3 C III 1 B PIH 80 70
230 Jaya 4 E I 4 D OB 129 120
231 Prema 1 D IV 4 B SA 100 99
232 Ponni 2 E I 1 C PIH,G 110 128
233 Komalavalli 3 D IV 2 B 120 110
234 Venda 3 D + I 3 D OB 66 65
235 Kannagi 2 C II 4 B USB H 120 116
236 Uma 3 E I 1 B PIH 84 87
237 Kanaga 1 D + I 2 C 110 98
238 Veda 3 E II 3 D SID OB 100 106
239 Neela 4 D I 4 B 67 69
240 Rani 2 E I 3 B 84 87
241 Karpagam 3 D III 4 D OB 124 128
242 Kamala 2 E I 2 B 116 100
243 Radha 3 D I 3 C 62 67
244 Parvathi 1 E II 2 B PIH MON 100 106
245 Jeba 3 D I 4 D OB 90 94
246 Chinnathayi 3 C III 3 B M 96 88
247 Rajathi 4 E I 1 B PIH 61 71
248 Umapriya 2 D I 4 C 116 118
249 Sarojini 3 E + II 4 B PIH PIH 124 126
250 Ramayee 1 D I 2 B 80 79
251 Baby 3 E + I 1 B 86 94
252 Alli 3 C II 3 B USB 96 88
253 Therasa 2 D I 4 C G 66 64
254 Vanaja 3 E I 3 B 106 124
255 Ajitha 1 D + I 2 B CA 126 109
256 Salma 4 E II 4 B 100 98
257 Saraswathy 3 C II 3 B 89 82
258 Vishalam 4 D II 4 A PIH 120 118
259 Anjali 2 E I 2 A 110 100
260 Prabha 3 E II 3 C G 80 77
261 Samitha 2 D I 4 B PIH 84 87
262 Selvi 3 E II 3 D OB 94 110
263 Amala 4 D I 1 B CA 126 128
264 Riswana 1 C + I 2 C 94 100
265 Aruna 3 D + III 4 B SA PIH 121 128
266 Krishnaveni 2 E I 3 A 90 80
267 Maya 3 D IV 1 D 78 89
268 Rupa 3 E I 4 C OB 130 124
269  Annam 3 D + I 2 B 106 104
270 Periyanayaki 1 C II 3 B USB 100 98
271 Panchalai 4 D I 4 B PIH 130 121
272 Mangammal 3 E II 3 B 110 116
273 Pramila 2 D I 2 B 118 104
274 Kavitha 3 E III 4 B 94 96
275 Kalpana 3 D I 3 B 116 118
276 Punitha 2 E I 2 B 61 67
277 Kumudha 1 D II 3 C 100 89
278 Shanthakumari 3 E I 4 B 68 70
279 Tamilarasi 3 D II 4 B M MON 90 100
280 Chellammal 4 C + I 1 B PIH 124 110
281 Raji 2 E + III 2 C RU 107 121
282 Ranganayaki 3 D I 3 D OB 100 92
283 Kaliyammal 1 E I 1 A H 90 96
284 Vaidegi 3 D II 4 C SID G 116 118
285 Manju 4 E I 2 B 64 71
286 Savithri 2 C I 3 B PIH 74 66
287 Maria 3 D + III 4 B SA 106 108
288 Rajini 3 E I 2 D OB 90 96
289 Mehaboob 4 D IV 4 B 95 88
290 Nalini 3 E I 3 B 80 78
291 Kowsalya 1 D II 4 B 116 120
292 Chinnaponnu 3 E I 2 B PIH 96 98
293 Solay 4 E I 2 B 94 93
294 Panchalai 2 D II 3 D OB,PIH,G 112 116
295 Jayalakshmio 3 E I 4 A 66 74
296 Ruckmani 3 D I 2 C MON 76 61
297 Divya 2 E II 3 B 62 64
298 Kanaga 3 E + I 1 D OB,H 94 88
299 Pechi 1 C + I 3 B PCA 89 96
300 Pattu 4 D II 4 B RU,PIH 124 126
301 Narayani 3 C I 1 C 74 76
302 Kasthuri 3 E I 2 B 104 107
303 Pushpa 2 D + III 3 B UND PIH 124 116
304 Malleswari 4 E I 4 C G 118 128
305 Usha 3 D II 1 D OB 96 94
306 Kasimbee 1 E I 2 B 65 64
307 Bharani 3 D II 3 B 88 87
308 Rajeswari 2 E I 2 B 94 106
309 Sayeedha 3 D II 4 D OB 107 94
310 Chithra 3 E I 1 B 92 109
311 Maheshwari 1 D III 2 B SA 102 91
312 Sulekha 3 E I 3 C 84 87
313 Ponnammal 2 D II 2 D OB 74 77
314 Kamala 3 E I 3 B 76 72
315 Govindammal 4 D |+ I 1 B 94 97
316 Lakshmi 2 C II 4 C PIH MON 124 127
317 Sundari 3 D I 2 A 106 104
318 Kalaiarasi 1 E I 3 D OB,RU 74 77
319 Vaidegi 4 D + I 4 B 94 97
320 Aachi 3 E I 2 C G 112 127
321 Santhanalakshmi 2 D II 3 B USB 84 87
322 Kamala 3 E I 4 B 124 118
323 Chithra 3 D II 3 D HG OB 94 97
324 Veeralakshmi 3 E I 2 C 106 107
325 Selvi 1 D I 3 B 84 87
326 Muniammal 3 E IV 3 B SID 116 118
327 Vanitha 3 E + I 1 B M 94 96
328 Jeynabee 2 E II 2 D OB 124 128
329 Surekha 3 C I 3 B 62 61
330 Kumari 1 D I 4 B 84 87
331 Pushpa 4 E + II 2 C UND 94 104
332 Dhana 3 E I 3 B 106 98
333 Violet 2 D I 4 D OB 124 132
334 Noor 3 E II 3 B USB PIH 112 114
335 Saraswathy 4 C I 4 B 66 65
336 Rani 3 D III 2 C M G 84 87
337 Rohini 4 E + I 1 D OB 106 99
338 Revathy 1 D IV 3 B SA 94 104
339 Ponni 3 E I 4 A 72 71
340 Porkodi 2 D IV 2 B 112 117
341 Lakshmi 3 E I 3 C 69 70
342 Maragatham 3 D + I 4 B M 84 87
343 Rathi 3 C II 3 D OB 104 107
344 Rosy 3 d I 1 A M 106 110
345 Jaya 2 E II 2 B 90 88
346 Lily 1 B I 3 C G 69 64
347 Nagalakshmi 4 E + I 4 D OB 96 95
348 Jyothi 3 D II 2 B M M 104 116
349 Shanmugavalli 2 C I 3 B PIH 112 116
350 Akila 3 E I 2 C 66 69
351 Gomathy 3 D + II 4 D OB 88 89
352 Sundhari 4 E I 2 B 74 72
353 Sakthi 1 D I 3 B 106 110
354 Sona 2 C II 4 B PIH 124 127
355 Jamuna 3 E I 4 D OB 104 114
356 Kamakshi 3 D + III 3 C SA M 116 120
357 Vinodha 2 E I 2 A 68 69
358 Ramani 3 D II 4 B 84 89
359 Loganayagi 3 D I 4 B 101 104
360 Yamini 1 D IV 4 B M 107 109
361 Senbagam 3 D I 1 C 84 87
362 Vimala 2 E I 4 A 62 67
363 Yamini 3 D II 2 D OB 94 98
364 Idhaya 1 C I 3 B M 124 128
365 Roshini 3 D + II 4 B PIH PIH 89 88
366 Jaya 2 E I 2 B 64 62
367 Vinitha 4 D II 3 B G 120 116
368 Buela 3 C I 4 D OB 124 132
369 Sandhya 3 C + II 1 B USB 94 106
370 Carolene 5 E I 4 C 80 78
371 Jaba 3 D III 2 B PIH 106 98
372 Krishnaveni 4 E I 3 D OB 124 127
373 Vennila 1 D I 4 B 66 64
374 Valli 3 E III 2 B SID M 112 114
375 Shobana 2 E I 4 B 82 89
376 Sumitha 3 D I 3 B PIH 101 104
377 Shobana 3 E II 4 C 124 127
378 Selvi 3 D I 1 B 84 87
379 Devi 2 E II 4 D OB 105 107
380 Ponni 1 E I 2 B M 124 127
381 Angammal 3 D I 3 C 100 98
382 Ayyammal 3 E II 4 B USB CA 132 134
383 Ramya 3 D + I 2 B H 126 130
384 Roja 2 C II 1 D OB 94 97
385 Malliga 4 D I 4 A G 124 126
386 Buela 3 E III 3 C SA RU 116 118
387 Vanitha 1 E + I 4 C 80 78
388 Sree 4 E + II 2 B PIH 110 106
389 Kalyani 2 D I 4 B 90 88
390 Eswari 3 C IV 3 B SA 91 94
391 Sujatha 3 E I 4 B M 116 118
392 Sumathi 1 D II 1 B 84 87
393 Prema 3 E + I 4 B G 134 137
394 Dhineshi 2 D III 4 B 106 105
395 Sridevi 3 E I 4 B 101 109
396 Sangeetha 2 E II 2 A M 112 116
397 Muniammal 3 D I 2 B 90 94
398 Janani 1 E I 3 B 97 88
399 Janaki 3 C II 4 B G 124 127
400 Kani 3 E I 2 B 88 85
401 Maha 2 D I 4 C CA 105 109
402 Shanathamani 3 E II 1 D OB 116 120
403 Begam 3 E + I 3 B G 96 100
404 Ganga 3 D III 2 B SA RU 74 77
405 Shakunthala 2 C I 4 B 134 136
406 Pushpa 1 E + III 4 B SID 106 108
407 Kalaiarasi 3 D I 2 B M 94 96
408 Sundharambal 3 E I 1 B CA 84 87
409 Eswari 2 E IV 3 B 74 77
410 Deivanai 3 D I 2 B 124 128
411 Devammal 3 C II 4 B M 106 108
412 Parvathy 3 E I 1 B 98 88
413 Vidhyavathy 2 B II 4 C PIH M 104 107
414 Emelda 3 E I 2 B G 90 94
415 Ramasubamma 3 C III 3 A SA 105 95
416 Yeesamal 1 D I 4 B RU 124 127
417 Parameshwari 3 E II 3 B 76 79
418 Meenammal 4 D I 2 B MON 94 104
419 Mekala 2 E + I 4 C 104 107
420 Thenmozhi 3 E II 3 D OB 134 138
421 Gloria 3 D I 1 B M 112 114
422 Padmapriya 3 E II 2 A PIH 76 79
423 Parvathy 2 D I 4 B 104 107
424 Anandhavalli 3 C III 3 C MG 96 90
425 Pavunu 1 E I 4 B M 120 124
426 Kalaivani 3 D II 2 D OB 127 116
427 Gowri meena 2 E I 4 C 88 96
428 Gnanamani 3 D II 1 B 116 117
429 Asha 3 E + I 1 B 86 87
430 Renuga 3 E II 4 C M 105 109
431 Hemavathy 2 D I 2 B 77 80
432 Thayalanam 3 C II 3 A 94 97
433 Kumari 1 D I 4 B SID 116 124
434 Aach kannu 3 B II 2 B 104 107
435 Bagavathi ammal 3 D I 3 C 84 87
436 Banupriya 2 D IIII 4 D OB 124 116
437 Umapriya 3 E + I 2 C G 106 96
438 Jennifer 3 C II 1 B PIH 96 105
439 Nagarani 1 D I 3 B 74 74
440 Saritha 3 E III 4 C MG 106 116
441 Athabiya 3 D I 2 B 86 86
442 Anbarasi 2 E I 4 B M 116 106
443 Jeyaseeli 3 C II 3 C 95 97
444 Visalam 1 D + I 2 B PIH 116 118
445 Visalakshi 3 E I 4 B 104 107
446 Killiammal 3 E I 4 C 86 84
447 Komala 2 D II 2 B PIH M 124 127
448 Thilagavathy 3 E  I 3 B 74 79
449 Agalya 1 D I 4 C G 112 106
450 Esthermary 3 C III 2 B SA 84 87
451 Kalarani 3 E I 3 D OB 94 9
452 Pappathy 2 D I 1 A M 107 116
453 Jeevarathinam 1 B II 4 B MON 118 119
454 Nagavalli 3 D + I 2 C 80 79
455 Nageshwari 3 E II 3 B USB 124 119
456 Asirvatham 2 D + 1 4 D OB 104 107
457 Mangammal 3 C II 4 P UND 97 94
458 Vijayavalli 3 D I 1 C G 116 132
459 Kamini 1 E I 2 B 110 108
460 Kumudha valli 3 D + II 3 B PIH 134 116
461 Denamuthu 3 E I 4 B 86 84
462 Marychitra 3 D I 2 B 116 120
463 Kanagapriya 2 C I 1 C 110 104
464 Rajeswari 3 D II 4 C 96 101
465 Roopa 1 E I 3 A 69 67
466 Suguna 3 C II 2 B G 76 75
467 Swarna 3 D + I 4 B RU 124 127
468 Sofiya 2 B III 4 C SA 106 100
469 Soliammal 3 D + I 3 B M 88 90
470 Thirumaiselvi 3 E II 4 D OB 101 110
471 Jothi 1 C I 4 B 134 137
472 Hazel 3 D III 1 C HG 74 77
473 Thangammal 3 E I 2 B 65 67
474 Udaya 3 D + III 4 B SA M 112 124
475 Narahini 2 E I 3 B PIH 96 98
476 Sundaravalli 3 D IV 4 B G 105 107
477 Niranjini 3 E I 3 B 124 120
478 Neeraja 3 C III 4 B PIH 118 116
479 Sundaradevi 2 D I 1 B 96 94
480 Cheeniyammal 3 D I 4 B 104 106
481 Kavithanjali 2 E + I 1 B 116 124
482 Sarojammal 3 D II 3 C USB 74 76
483 Bhavani 1 E I 2 C G 124 120
484 Swarnalakshmi 3 C I 4 B 88 86
485 Tamilarasi 3 D III 3 A SA 94 97
486 Tamilselvi 2 B I 4 B M 116 112
487 Ponnammal 3 D + II 2 D OB 132 134
488 Subbulakshmi 3 E I 1 C 101 105
489 Rahmath begam 1 E II 3 B M MON 116 109
490 Farana 3 D I 4 C 108 117
491 Kasturi bai 3 C II 3 A G 84 87
492 Barathikannamma 2 E I 4 B PIH 124 134
493 Anuradha 3 E III 4 B 72 76
494 Rachol 3 D + I 3 B 136 126
495 Ellammal 3 E II 1 B 106 96
496 Sudha 4 D I 3 B 98 105
497 Sasikala 3 C I 3 B 110 108
498 Bala 2 D III 4 B SA 107 102
499 Mobina 3 E + I 1 A 74 79
500 Johnsirani 1 D I 4 C G 112 106
501 Saramma 3 B II 3 B 88 85
502 Udaya 3 C I 4 C 94 100
503 Leena 2 D I 2 B PIH 130 119
504 Moihana 3 E + II 3 C 110 106
505 Asiyabee 3 D I 4 B M 88 84
506 Srinivasini 1 E III 1 B 136 130
507 Usha 3 D I 3 D OB 120 138
508 Padmapriya 3 C II 4 B 74 76
509 Angaiyarkani 2 E + I 3 B G 130 124
510 Shanthi 3 D I 4 C 104 107
511 Abibha 1 E III 3 B 96 94
512 Syamala 3 C I 4 B 112 121
513 Zeelanini 3 D IV 3 B 104 107
514 Hemavathy 3 E I 4 B PIH 91 88
515 Malar 2 D II 1 B PIH 110 108
516 Yuvarani 1 E + I 2 C 64 62
517 Gowthami 3 D I 3 C G 76 74
518 Muneshwari 3 B III 4 B USB 84 92
519 Devibala 3 C I 4 A MON 112 114
520 Julimargaret 2 D I 3 B 104 107
521 Sasikala 3 E + I 4 B 86 82
522 Suchitra 3 D I 1 C M 68 66
523 Zaheera  begam 1 E II 2 B G 104 116
524 Saira Banu 3 D III 3 D SA OB 126 124
525 Deepa 3 C + I 4 B 74 76
526 Thenmozhi 2 D II 3 C 132 134
527 Deivamalar 3 E I 1 B 92 96
528 Anjalatchi 3 D II 4 B 112 114
529 Uma 3 D III 4 B PIH 104 107
530 Ezhilarasi 2 E I 3 B 86 85
531 Ramani 2 E I 1 C 84 82
532 Pramila 1 D II 4 B 104 102
533 Vanilla 3 B I 2 B 77 79
534 Inora 2 E I 3 A 116 106
535 Julia 1 C II 4 C G 96 94
536 Thangamani 3 D I 3 B 104 112
537 Chengammal 3 B + II 4 B 102 104
538 Aiysha 2 D I 1 D OB, M 132 137
539 Renugadevi 3 D I 2 B 86 89
540 Ambika 2 E III 3 C 72 75
541 Mohana 1 D I 4 B 118 122
542 Navaneshwari 3 E III 3 B SID 97 92
543 Vigneshwari 3 C I 2 B 122 113
544 Ponselvi 2 D I 4 C 106 109
545 Sharmila 3 E III 1 B 82 85
546 Shakila 3 D I 3 B 112 122
547 Vasuki 3 E IV 4 B G 126 118
548 Gowri 3 E I 4 B 83 96
549 Kala 1 E II 1 C PIH 102 105
550 Manimegalai 3 D I 3 B 92 88
551 Sankari 3 E I 2 C 82 88
552 Chittammal 2 C I 4 B G 122 139
553 Anitha 2 D II 4 C USB 78 75
554 Karpagam 3 E + I 3 A 113 116
555 Ganga 3 D I 2 B M 132 123
556 Ponni 1 E II 1 B SID MON 96 102
557 Thulasi 3 D + I 4 B 107 93
558 Bindhu 2 E III 3 B SA OB 103 113
559 Indhu 2 D III 4 B 115 125
560 Varalakshmi 1 C + I 4 C 96 91
561 Sakthi 3 D III 1 B SA 122 115
562 Gowrimeena 3 E I 2 B 86 83
563 Hemalatha 2 D IV 3 B 103 109
564 Indirani 4 E I 4 B PIH 126 128
565 Dhanam 3 E I 4 B 85 84
566 Masthan bee 1 D II 2 B PIH 105 99
567 Emily mary 3 E I 4 B 66 63
568 Suna 3 D III 3 C SA G 94 106
569 Nilavazhagi 2 C I 3 A RU 77 68
570 Nistha 3 D II 2 C HG 105 115
571 Barathy 1 E I 1 B M 85 86
572 Rathi 3 D + II 4 B CA 111 116
573 Anbu 3 E I 4 B G 62 75
574 Sahayamary 2 D I 3 B 105 103
575 Vanitha 3 C I 4 C RU 132 113
576 Jeevalakshmi 1 E + II 2 B PIH 76 72
577 Jeeva 3 D I 3 B 95 99
578 Jagadeshwari 2 E II 4 B 111 131
579 Amulamma 3 D I 3 B 88 83
580 Pushpalatha 3 E III 4 D PIH OB 101 103
581 Jayachitra 4 D I 3 C 123 125
582 Stella 3 E I 4 B 94 85
583 Gajalakshmi 1 D III 1 C 64 69
584 Rekha 3 E I 3 B G 85 92
585 Princy 2 D I 4 B 102 112
586 Kamala 2 E + I 3 C RU 76 72
587 Anajali 3 C III 2 B SA 111 106
588 Bhavani 3 D I 4 C 92 96
589 Monika 3 E II 3 D OB 63 75
590 Jamila 3 D I 4 A 109 103
591 Jenitha 3 E + II 3 B PIH 105 102
592 Kanchana 4 D I 1 B 112 114
593 Selvi 1 E II 2 B 72 68
594 Chitrangi 3 D I 3 C G 132 131
595 Girija 3 E IV 4 B 96 103
596 Gunaboopathy 3 D III 3 B 82 88
597 Selviraja 3 E I 4 B 102 95
598 Sarala 4 D III 3 B SA 123 129
599 Jabeena 3 D I 4 B 99 89
600 Yaswanthi 3 E II 2 C 73 74
601 Jeyanthi selvam 3 C I 4 D OB 85 92
602 Latha kutti 1 D III 1 A SA 105 112
603 Baranikumari 2 E I 4 C G 112 104
604 Ramapraba 2 D + I 3 B 73 75
605 Soorya 3 E II 4 B M 131 137
606 Annaiviolet 3 D I 4 C 111 113
607 Jeneth 3 E I 2 B 95 82
608 Dalia 4 E II 1 B 85 92
609 Betsy 2 C I 3 B 132 135
610 Amalavathy 1 E I 4 B G 112 123
611 Abiba 3 D I 2 B 125 120
612 Jayashree 3 E III 3 B SA 99 95
613 Tulasi 3 D I 4 C 105 103
614 Mallini 2 E I 4 B 124 126
615 Amsavalli 3 D III 4 B G 122 124
616 Ilayarani 4 D I 4 B 116 106
617 Elavarasi 3 E II 1 C 84 87
618 Murugeshwari 3 D I 2 B 106 116
619 Dhanalakshmi 2 C III 3 C PIH 94 97
620 Sheeladevi 1 C I 4 A RU 64 63
621 Epsy 3 D II 2 B M 104 107
622 Samundeeshwari 3 E + I 3 C G 109 102
623 Palayam 4 D II 1 B USB 74 76
624 Deivanai 2 D I 4 B PIH 124 120
625 Pornima 2 C III 3 B SA 96 95
626 Durga Devi 3 E + I 2 D OB.M 116 124
627 Meenaselvi 5 D II 4 B 64 67
628 Kalavathy 3 E I 1 B 90 77
629 Kulanthaiammal 4 D II 4 B PIH 105 107
630 Sudhaselvaraj 3 C I 2 C 74 82
631 Vadivammal 4 E III 3 B 94 97
632 Noori 3 E II 4 B G 124 127
633 Manju 3 E I 4 B 116 124
634 Anju 5 D I 1 B 94 92
635 Dilsath 3 D I 2 C G 80 78
636 Usha 3 E II 4 B PIH 126 116
637 Nirmala 2 C I 3 C 84 87
638 Mary manjula 4 D I 2 A 110 107
639 Shalini 3 D + II 1 B 134 137
640 Pushpavathy 2 C I 4 B RU 96 104
641 Sasirekha 3 E III 3 C SA 124 112
642 Sophiya 4 E I 2 B 72 74
643 Girija 2 D II 4 B PIH G 116 124
644 Kavya 4 C I 1 B 124 127
645 Kanimozhi 3 D I 4 B 86 94
646 Kamatchi 4 D II 2 B 96 88
647 Karpagam 3 E I 4 B 74 86
648 Selvarani 3 D IV 4 B PIH 124 132
649 Sripriya 5 E III 4 C SA G 134 128
650 Venkatalakshmi 3 E I 4 B 116 112
651 Sadana 5 D II 4 C 94 88
652 Nalayini 3 E I 1 D 87 92
653 Salimi 4 D I 2 C 106 116
654 Suniya 2 C II 4 B PIH G 118 109
655 Fathima 3 C + I 3 A 100 88
656 Rajitha 3 D III 2 B SA 84 96
657 Ramya 4 D I 1 C 132 124
658 Vimaldevi 3 E II 4 B PIH 76 86
659 Lakshmi 3 D I 3 B OB 106 104
660 Kanimozhi 5 C I 2 B 124 132
661 Rajalakshmi 2 E III 1 B SA G 84 92
662 Veera kumari 3 D + I 4 C 127 124
663 Meenakumari 4 D I 3 B 94 89
664 Sowmiya 3 E II 4 B PIH 124 132
665 Ujjaini 3 D I 2 C 104 106
666 Srikala 4 E III 4 B SA 132 128
667 Rameshwari 3 C III 4 B 120 110
668 Tamilselvi 5 D I 4 B 106 116
669 Ramapraba 3 E II 4 B G 99 88
670 Kalavathy 4 D I 1 B 87 92
671 Jaya Lakshmi 3 C I 4 C 116 118
672 Pattammal 2 D I 3 B G 74 82
673 Kanchana 3 E + II 2 B 106 107
674 Mayoori 3 D II 4 B 84 87
675 Sindhu 4 C I 1 C 132 126
676 Baranikumari 3 D II 4 A G 106 96
677 Kalaiarasi 5 E I 3 B 110 108
678 Anabika 3 E III 2 B SA 124 132
679 Arasi 4 E II 4 B 84 87
680 Betty 3 E II 1 B 106 108
681 Buvaneshwari 4 D III 4 B SA 124 132
682 Rupavathy 3 E II 4 B G 136 126
683 Hemaselvaraj 3 E IV 4 B SA 122 124
684 Harini 3 E II 3 C 126 122
685 Jebamary 4 E III 4 B SA 134 136
686 Kalyani 3 C II 3 B 86 84
687 Logammal 5 E II 4 B G 124 116
688 Rajathi 3 E V 3 B SA, SID 105 107
689 Bairavi 3 C II 4 B 112 124
690 Mangammal 4 E II 2 B RU 106 108
691 Mala 3 E III 4 B 74 82
692 Brindia 5 C II 1 C PIH 116 124
693 leena 4 E IV 4 B 84 88
694 Pongudi 3 D III 4 B SA 128 118
695 Iyyammal 3 E II 4 B G 106 96
696 Swetha 4 E III 3 B SA 134 134
697 Akila 3 C IV 4 C 104 106
698 kulanthai Teresa 5 D II 4 B 84 87
699 Maheshwari 3 E V 4 B G 136 128
700 Lilly 3 E II 4 B 128 132
701 Amudha 3 E II 4 C 121 118
702 Vennila 5 E III 4 B SA G 86 84
703 Renugadevi 3 C II 4 B 112 124
704 Shanmathi 2 E V 3 B 106 107
705 Ramya 3 E II 4 B 67 65
706 Selviravi 3 E I 3 C 124 127
707 Saritha 3 E II 4 B G 104 112
708 Ambiga 5 E VI 4 B SA 114 110
709 Priya 2 E III 3 B 81 85
710 Jesinthamary 3 C VI 4 C M, UND 78 82
711 Kala 5 E III 4 B SA G 106 112
712 Shanmuga valli 3 E II 3 C 112 114
713 Pragadeswari 5 E II 4 B 84 87
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